Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Journal of Cosmetic Dermatology|October 22, 2020
The efficacy and safety of topical tranexamic acid (liposomal or lotion with microneedling) versus conventional hydroquinone in the treatment of melasmaXiaoxue Xing, Li Chen, Zhongyi Xu, et al.Journal of Dermatological Science|April 13, 2020
585 nm light-emitting diodes inhibit melanogenesis through upregulating H19/miR-675 axis in LEDs-irradiated keratinocytes by paracrine effectShanglin Jin, Li Chen, Zhongyi Xu, et al.Experimental Dermatology|December 4, 2021
Tranexamic acid inhibits melanogenesis partially via stimulation of TGF-β1 expression in human epidermal keratinocytesXiaoxue Xing, Zhongyi Xu, Li Chen, et al.The Journal of Investigative Dermatology|March 7, 2018
CCN1/Cyr61 Stimulates Melanogenesis through Integrin α6β1, p38 MAPK, and ERK1/2 Signaling Pathways in Human Epidermal MelanocytesZhongyi Xu, Li Chen, Min Jiang, et al.Annals of Dermatology|April 29, 2021
Severe Cutaneous Adverse Reactions: A Single-Center Retrospective Study of 173 Patients in ChinaZhongyi Xu, Jie Shen, Yiwen Yang, et al.Molecular Medicine Reports|July 6, 2013
Multinucleated cells are involved in normal development and apoptosis in mouse testesLan Luo, Yuhong Li, Yuling Yang, et al.Cell Death Discovery|May 8, 2020
Dysfunction of ATG7-dependent autophagy dysregulates the antioxidant response and contributes to oxidative stress-induced biological impairments in human epidermal melanocytesZhuhui Qiao, Zhongyi Xu, Qing Xiao, et al.Micromachines|July 28, 2026
Gray Wolf Optimization-Long Short-Term Memory Based Temperature Estimation and Closed-Loop Control Method in Microfluidic Chemiluminescence ImmunoassayXu Xu, Zhongyi Xu, Chuan Lyu, et al.Journal of Dermatological Science|February 27, 2020
Exogenous hydrogen sulfide inhibits human melanoma cell development via suppression of the PI3K/AKT/ mTOR pathwayQing Xiao, Jiayi Ying, Zhuhui Qiao, et al.The Journal of Dermatological Treatment|October 17, 2025
Long-term efficacy and safety of oral abrocitinib combined with narrow-band UVB phototherapy in non-segmental vitiligo: a 52-week prospective studyZhongyi Xu, Yijie Xuan, Zhe Zhu, et al.Pageof 4